Business description: Carmat

Sales by Activity: Carmat
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Medical Products | 9.33K | 2.24M | 477K | 3.84M | 7.34M |
Geographical breakdown of sales: Carmat
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Export | - | 2.23M | 205K | 1.47M | 3.59M |
France | 9.33K | - | 140K | 1.33M | 3.38M |
Unallocated | - | 8K | 132K | 1.04M | 375K |
Executive Committee: Carmat
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
CEO | Chief Executive Officer | 55 | 2016-08-31 |
| Director of Finance/CFO | - | 2018-12-11 | |
| Chief Tech/Sci/R&D Officer | - | 2025-03-31 | |
Marc Grimmé
CTO | Chief Tech/Sci/R&D Officer | - | 2009-11-30 |
| Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Carmat
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
BRD | Director/Board Member | 55 | - |
| Director/Board Member | 68 | 2017-01-01 | |
Michael Mack
BRD | Director/Board Member | 79 | 2017-04-19 |
Pierre Bastid
CHM | Chairman | 71 | 2024-06-24 |
| Director/Board Member | 63 | 2021-05-06 | |
David Coti
BRD | Director/Board Member | 41 | 2021-05-06 |
John Hernandez
BRD | Director/Board Member | 59 | 2021-05-06 |
| Director/Board Member | 64 | 2022-12-31 | |
Paolo Rampulla
BRD | Director/Board Member | 54 | 2022-12-31 |
Laurent Kirsch
BRD | Director/Board Member | 58 | 2023-03-10 |
Company details: Carmat

Medical Devices & Implants
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.38% | -11.79% | -29.88% | -4.89% | 106B | ||
| -0.05% | -3.48% | -28.54% | -3.89% | 11.68B | ||
| -2.84% | +0.14% | +97.77% | +141.72% | 10.6B | ||
| -2.44% | -2.12% | -53.99% | -70.46% | 4.08B | ||
| -1.83% | -1.40% | -27.79% | +35.95% | 2.42B | ||
| -2.58% | -5.27% | - | - | 1.88B | ||
| +6.98% | +5.41% | -18.40% | -70.39% | 1.92B | ||
| -1.28% | -0.81% | -22.29% | -27.52% | 1.55B | ||
| Average | -0.55% | -1.70% | -11.88% | +0.07% | 17.47B | |
| Weighted average by Cap. | -0.56% | -8.90% | -20.39% | +4.08% |

















